485 related articles for article (PubMed ID: 27717710)
1. Dysregulation of histone methyltransferases in breast cancer - Opportunities for new targeted therapies?
Michalak EM; Visvader JE
Mol Oncol; 2016 Dec; 10(10):1497-1515. PubMed ID: 27717710
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations of histone lysine methyltransferases and their significance in breast cancer.
Liu L; Kimball S; Liu H; Holowatyj A; Yang ZQ
Oncotarget; 2015 Feb; 6(4):2466-82. PubMed ID: 25537518
[TBL] [Abstract][Full Text] [Related]
3. PELP1 oncogenic functions involve CARM1 regulation.
Mann M; Cortez V; Vadlamudi R
Carcinogenesis; 2013 Jul; 34(7):1468-75. PubMed ID: 23486015
[TBL] [Abstract][Full Text] [Related]
4. The role of histone modifications and variants in regulating gene expression in breast cancer.
Dalvai M; Bystricky K
J Mammary Gland Biol Neoplasia; 2010 Mar; 15(1):19-33. PubMed ID: 20131086
[TBL] [Abstract][Full Text] [Related]
5. [Histone methyltransferases: a new class of therapeutic targets in cancer treatment?].
Chaib H; Prébet T; Vey N; Collette Y
Med Sci (Paris); 2011; 27(8-9):725-32. PubMed ID: 21880260
[TBL] [Abstract][Full Text] [Related]
6. Histone methyltransferase inhibitors: novel epigenetic agents for cancer treatment.
Zagni C; Chiacchio U; Rescifina A
Curr Med Chem; 2013; 20(2):167-85. PubMed ID: 23210854
[TBL] [Abstract][Full Text] [Related]
7. [Advances in histone methyltransferases and histone demethylases].
Wang X; Zhu WG
Ai Zheng; 2008 Oct; 27(10):1018-25. PubMed ID: 18851779
[TBL] [Abstract][Full Text] [Related]
8. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.
Morera L; Lübbert M; Jung M
Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic small molecule modulators of histone and DNA methylation.
Hauser AT; Robaa D; Jung M
Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence-based methods for screening writers and readers of histone methyl marks.
Allali-Hassani A; Wasney GA; Siarheyeva A; Hajian T; Arrowsmith CH; Vedadi M
J Biomol Screen; 2012 Jan; 17(1):71-84. PubMed ID: 21972038
[TBL] [Abstract][Full Text] [Related]
11. Targeting Histone Methylation in Cancer.
McCabe MT; Mohammad HP; Barbash O; Kruger RG
Cancer J; 2017; 23(5):292-301. PubMed ID: 28926430
[TBL] [Abstract][Full Text] [Related]
12. Histone modification therapy of cancer.
Biancotto C; Frigè G; Minucci S
Adv Genet; 2010; 70():341-86. PubMed ID: 20920755
[TBL] [Abstract][Full Text] [Related]
13. Protein arginine methyltransferases: promising targets for cancer therapy.
Hwang JW; Cho Y; Bae GU; Kim SN; Kim YK
Exp Mol Med; 2021 May; 53(5):788-808. PubMed ID: 34006904
[TBL] [Abstract][Full Text] [Related]
14. Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer.
Mohammad HP; Barbash O; Creasy CL
Nat Med; 2019 Mar; 25(3):403-418. PubMed ID: 30842676
[TBL] [Abstract][Full Text] [Related]
15. Histone lysine methyltransferases as anti-cancer targets for drug discovery.
Liu Q; Wang MW
Acta Pharmacol Sin; 2016 Sep; 37(10):1273-1280. PubMed ID: 27397541
[TBL] [Abstract][Full Text] [Related]
16. Genomic Location of PRMT6-Dependent H3R2 Methylation Is Linked to the Transcriptional Outcome of Associated Genes.
Bouchard C; Sahu P; Meixner M; Nötzold RR; Rust MB; Kremmer E; Feederle R; Hart-Smith G; Finkernagel F; Bartkuhn M; Savai Pullamsetti S; Nist A; Stiewe T; Philipsen S; Bauer UM
Cell Rep; 2018 Sep; 24(12):3339-3352. PubMed ID: 30232013
[TBL] [Abstract][Full Text] [Related]
17. Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding proteins.
Tryndyak VP; Kovalchuk O; Pogribny IP
Cancer Biol Ther; 2006 Jan; 5(1):65-70. PubMed ID: 16322686
[TBL] [Abstract][Full Text] [Related]
18. PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 Expression.
Chiang K; Zielinska AE; Shaaban AM; Sanchez-Bailon MP; Jarrold J; Clarke TL; Zhang J; Francis A; Jones LJ; Smith S; Barbash O; Guccione E; Farnie G; Smalley MJ; Davies CC
Cell Rep; 2017 Dec; 21(12):3498-3513. PubMed ID: 29262329
[TBL] [Abstract][Full Text] [Related]
19. Structure and function of histone methyltransferases.
Trievel RC
Crit Rev Eukaryot Gene Expr; 2004; 14(3):147-69. PubMed ID: 15248813
[TBL] [Abstract][Full Text] [Related]
20. Histone-modifier gene expression profiles are associated with pathological and clinical outcomes in human breast cancer.
Patani N; Jiang WG; Newbold RF; Mokbel K
Anticancer Res; 2011 Dec; 31(12):4115-25. PubMed ID: 22199269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]